Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Abe, Jiro"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-11 z 11
    Tytuł:
    A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ gene.
    Autorzy:
    Takeda A; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Ueki M; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Abe J; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
    Maeta K; KNC Department of Nucleic Acid Drug Discovery, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan.; Research Center for Locomotion Biology, Kobe Gakuin University, Kobe, Japan.
    Horiguchi T; KNC Department of Nucleic Acid Drug Discovery, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan.; Research Center for Locomotion Biology, Kobe Gakuin University, Kobe, Japan.
    Yamazawa H; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Izumi G; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Chida-Nagai A; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Sasaki D; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Tsujioka T; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Sato I; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Shiraishi M; Department of Pediatrics, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
    Matsuo M; KNC Department of Nucleic Acid Drug Discovery, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan.; Research Center for Locomotion Biology, Kobe Gakuin University, Kobe, Japan.; Faculty of Health Sciences, Kobe Tokiwa University, Kobe, Japan.
    Pokaż więcej
    Źródło:
    Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2023 Jul; Vol. 11 (7), pp. e2190. Date of Electronic Publication: 2023 Apr 25.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Barth Syndrome*/genetics
    Barth Syndrome*/pathology
    Cardiomyopathies*/genetics
    Heart Defects, Congenital*/genetics
    Heart Failure*/genetics
    Humans ; Transcription Factors/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinical and genomic features of non-small cell lung cancer occurring in families.
    Autorzy:
    Miyabe S; Division of Thoracic Surgery, Miyagi Cancer Center Hospital, Natori, Japan.; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
    Ito S; Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
    Sato I; Division of Pathology, Miyagi Cancer Center Hospital, Natori, Japan.
    Abe J; Division of Thoracic Surgery, Miyagi Cancer Center Hospital, Natori, Japan.; Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
    Tamai K; Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
    Mochizuki M; Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
    Fujimori H; Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
    Yamaguchi K; Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
    Shindo N; Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
    Shima H; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.
    Yamazaki T; Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
    Abue M; Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
    Okada Y; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
    Yasuda J; Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
    Pokaż więcej
    Źródło:
    Thoracic cancer [Thorac Cancer] 2023 Apr; Vol. 14 (10), pp. 940-952. Date of Electronic Publication: 2023 Mar 03.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Carcinoma, Non-Small-Cell Lung*/genetics
    Carcinoma, Non-Small-Cell Lung*/pathology
    Lung Neoplasms*/genetics
    Lung Neoplasms*/pathology
    Humans ; Dihydroorotate Dehydrogenase ; Mutation ; Carcinogenesis/genetics ; Genomics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Transplantation of MITO cells, mitochondria activated cardiac progenitor cells, to the ischemic myocardium of mouse enhances the therapeutic effect.
    Autorzy:
    Sasaki D; Department of Pediatrics, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi 7, Kita-ku, Sapporo, 060-8638, Japan.
    Abe J; Department of Pediatrics, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi 7, Kita-ku, Sapporo, 060-8638, Japan.; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
    Takeda A; Department of Pediatrics, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi 7, Kita-ku, Sapporo, 060-8638, Japan.
    Harashima H; Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo, 060-0812, Japan.
    Yamada Y; Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo, 060-0812, Japan. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2022 Mar 22; Vol. 12 (1), pp. 4344. Date of Electronic Publication: 2022 Mar 22.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Myocardial Reperfusion Injury*/metabolism
    Myocytes, Cardiac*/metabolism
    Humans ; Mitochondria ; Myocardium/metabolism ; Stem Cells
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer.
    Autorzy:
    Nanamiya R; Department of Pathology, Tohoku University Graduate School of Medicin, Sendai 980-8575, Japan.
    Saito-Koyama R; Department of Pathology, Tohoku University Graduate School of Medicin, Sendai 980-8575, Japan.
    Miki Y; Department of Pathology, Tohoku University Graduate School of Medicin, Sendai 980-8575, Japan.
    Inoue C; Department of Pathology, Tohoku University Graduate School of Medicin, Sendai 980-8575, Japan.
    Asavasupreechar T; Department of Pathology, Tohoku University Graduate School of Medicin, Sendai 980-8575, Japan.
    Abe J; Department of Thoracic Surgery, Miyagi Cancer Center, Natori 981-1293, Japan.
    Sato I; Department of Pathology, Miyagi Cancer Center, Natori 981-1293, Japan.
    Sasano H; Department of Pathology, Tohoku University Graduate School of Medicin, Sendai 980-8575, Japan.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2021 Aug 07; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 07.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Adenocarcinoma of Lung*/drug therapy
    Adenocarcinoma of Lung*/genetics
    Adenocarcinoma of Lung*/metabolism
    Adenocarcinoma of Lung*/mortality
    Carcinoma, Non-Small-Cell Lung*/drug therapy
    Carcinoma, Non-Small-Cell Lung*/genetics
    Carcinoma, Non-Small-Cell Lung*/metabolism
    Carcinoma, Non-Small-Cell Lung*/mortality
    Lung Neoplasms*/drug therapy
    Lung Neoplasms*/genetics
    Lung Neoplasms*/metabolism
    Lung Neoplasms*/mortality
    Acrylamides/*pharmacology
    Aniline Compounds/*pharmacology
    Cell Cycle/*drug effects
    Neoplasm Proteins/*metabolism
    Receptor, EphB4/*metabolism
    A549 Cells ; Cell Cycle/genetics ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Humans ; Mutation ; Neoplasm Proteins/genetics ; Receptor, EphB4/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Suppression of tumor immune microenvironment via microRNA-1 after epidermal growth factor receptor-tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma.
    Autorzy:
    Kawana S; Department of Pathology, Tohoku University School of Medicine, Miyagi, Japan.; Department of Respiratory Medicine, Sendai Kousei Hospital, Miyagi, Japan.
    Saito R; Department of Pathology, Tohoku University School of Medicine, Miyagi, Japan.
    Miki Y; Department of Pathology, Tohoku University School of Medicine, Miyagi, Japan.
    Kimura Y; Department of Respiratory Medicine, Sendai Kousei Hospital, Miyagi, Japan.
    Abe J; Department of Thoracic Surgery, Miyagi Cancer Center, Miyagi, Japan.
    Sato I; Department of Pathology, Miyagi Cancer Center, Miyagi, Japan.
    Endo M; Department of Pathology, Sendai Kousei Hospital, Miyagi, Japan.
    Sugawara S; Department of Respiratory Medicine, Sendai Kousei Hospital, Miyagi, Japan.
    Sasano H; Department of Pathology, Tohoku University School of Medicine, Miyagi, Japan.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2021 Jan; Vol. 10 (2), pp. 718-727. Date of Electronic Publication: 2020 Dec 11.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Drug Resistance, Neoplasm*
    Adenocarcinoma of Lung/*immunology
    Lung Neoplasms/*immunology
    MicroRNAs/*genetics
    Protein Kinase Inhibitors/*pharmacology
    Tumor Microenvironment/*immunology
    Adenocarcinoma of Lung/drug therapy ; Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/pathology ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; ErbB Receptors/antagonists & inhibitors ; Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Prognosis ; Tumor Cells, Cultured
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Control of the Photo-Isomerization Mechanism in 3 H -Naphthopyrans to Prevent Formation of Unwanted Long-Lived Photoproducts.
    Autorzy:
    Brazevic S; Faculty of Physics, Adam Mickiewicz University in Poznan, Uniwersytetu Poznanskiego 2, 61-614 Poznan, Poland.
    Nizinski S; Faculty of Physics, Adam Mickiewicz University in Poznan, Uniwersytetu Poznanskiego 2, 61-614 Poznan, Poland.
    Sliwa M; Laboratoire de Spectroscopie pour les Interactions, la Réactivité et l'Environnement, LASIRE, CNRS, UMR 8516, Univ. Lille, 59000 Lille, France.
    Abe J; Department of Chemistry, School of Science and Engineering, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5258, Japan.
    Rode MF; Institute of Physics, Polish Academy of Sciences, Aleja Lotników 32/46, 02-668 Warsaw, Poland.
    Burdzinski G; Faculty of Physics, Adam Mickiewicz University in Poznan, Uniwersytetu Poznanskiego 2, 61-614 Poznan, Poland.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2020 Oct 22; Vol. 21 (21). Date of Electronic Publication: 2020 Oct 22.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Photochemical Processes*
    Benzopyrans/*chemistry
    Absorptiometry, Photon ; Isomerism ; Models, Chemical ; Spectrophotometry, Ultraviolet
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress.
    Autorzy:
    Yamada Y; Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
    Takano Y; Research Institute for Electronic Science, Hokkaido University, Kita-20 Nishi-10, Kita-ku, Sapporo 001-0020, Japan.
    Satrialdi; Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.; School of Pharmacy, Institut Teknologi Bandung, Ganesha 10, Bandung 40132, Indonesia.
    Abe J; Department of Pediatrics, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan.
    Hibino M; Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
    Harashima H; Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
    Pokaż więcej
    Źródło:
    Biomolecules [Biomolecules] 2020 Jan 05; Vol. 10 (1). Date of Electronic Publication: 2020 Jan 05.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Review
    MeSH Terms:
    Antioxidants/*pharmacology
    Mitochondria/*metabolism
    Oxidative Stress/*drug effects
    Antioxidants/metabolism ; Drug Delivery Systems/methods ; Drug Delivery Systems/trends ; Humans ; Mitochondria/drug effects ; Photochemotherapy/methods ; Photochemotherapy/trends
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells.
    Autorzy:
    Inoue C; Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 981-8575, Japan. chihiro_.
    Miki Y; Department of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science, Tohoku University, Sendai, Miyagi 980-8573, Japan.
    Saito R; Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 981-8575, Japan.
    Hata S; Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 981-8558, Japan.
    Abe J; Department of Thoracic Surgery, Miyagi Cancer Centre, Natori, Miyagi 981-1293, Japan.
    Sato I; Department of Pathology, Miyagi Cancer Centre, Natori, Miyagi 981-1293, Japan.
    Okada Y; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi 981-8575, Japan.
    Sasano H; Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 981-8575, Japan.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2019 Aug 27; Vol. 11 (9). Date of Electronic Publication: 2019 Aug 27.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Ex vivo model of non-small cell lung cancer using mouse lung epithelial cells.
    Autorzy:
    Sato T; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.; Department of Thoracic Surgery, Miyagi Cancer Center Hospital, Natori, Miyagi 981-1293, Japan.; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi 980-8575, Japan.
    Morita M; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Tanaka R; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.; Department of Thoracic Surgery, Miyagi Cancer Center Hospital, Natori, Miyagi 981-1293, Japan.; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi 980-8575, Japan.
    Inoue Y; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Nomura M; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Sakamoto Y; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Miura K; Department of Surgery, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Ito S; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Sato I; Tissue Bank, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Tanaka N; Division of Cancer Biology and Therapeutics, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Abe J; Department of Thoracic Surgery, Miyagi Cancer Center Hospital, Natori, Miyagi 981-1293, Japan.
    Takahashi S; Department of Thoracic Surgery, Miyagi Cancer Center Hospital, Natori, Miyagi 981-1293, Japan.
    Kawai M; Department of Breast Oncology, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.
    Sato M; Department of General Thoracic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima 890-8544, Japan.
    Hippo Y; Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba, Chiba 260-8717, Japan.
    Shima H; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.; Division of Cancer Molecular Biology, Tohoku University Graduate School of Medicine, Natori, Miyagi 981-1293, Japan.
    Okada Y; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi 980-8575, Japan.
    Tanuma N; Division of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Miyagi 981-1293, Japan.; Division of Cancer Molecular Biology, Tohoku University Graduate School of Medicine, Natori, Miyagi 981-1293, Japan.
    Pokaż więcej
    Źródło:
    Oncology letters [Oncol Lett] 2017 Dec; Vol. 14 (6), pp. 6863-6868. Date of Electronic Publication: 2017 Sep 28.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Long-term outcome of nitinol stenting to treat asphyxia caused by postpneumonectomy syndrome.
    Autorzy:
    Abe J; Department of Thoracic Surgery Miyagi Cancer Center Natori Japan; Department of Thoracic Surgery Sendai Medical Center Sendai Japan.
    Hasumi T; Department of Thoracic Surgery Sendai Medical Center Sendai Japan.
    Tanaka R; Department of Thoracic Surgery Miyagi Cancer Center Natori Japan; Department of Thoracic Surgery Sendai Medical Center Sendai Japan.
    Saito Y; Department of Thoracic Surgery Sendai Medical Center Sendai Japan.
    Kanma K; Department of Thoracic Surgery Sendai Medical Center Sendai Japan.
    Takahashi S; Department of Thoracic Surgery Miyagi Cancer Center Natori Japan.
    Pokaż więcej
    Źródło:
    Respirology case reports [Respirol Case Rep] 2016 Dec 01; Vol. 5 (1), pp. e00207. Date of Electronic Publication: 2016 Dec 01 (Print Publication: 2017).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Fatal broncho-pulmonary artery fistula after lobectomy for lung cancer†.
    Autorzy:
    Abe J; Department of Thoracic Surgery, Miyagi Cancer Center, Natori, Miyagi, Japan .
    Hasumi T; Department of Thoracic Surgery, Sendai Medical Center, Sendai, Miyagi, Japan.
    Takahashi S; Department of Thoracic Surgery, Miyagi Cancer Center, Natori, Miyagi, Japan.
    Tanaka R; Department of Thoracic Surgery, Miyagi Cancer Center, Natori, Miyagi, Japan.
    Sato T; Department of Thoracic Surgery, Miyagi Cancer Center, Natori, Miyagi, Japan.
    Okazaki T; Department of Thoracic Surgery, Miyagi Cancer Center, Natori, Miyagi, Japan.
    Pokaż więcej
    Źródło:
    Journal of surgical case reports [J Surg Case Rep] 2015 Sep 04; Vol. 2015 (9). Date of Electronic Publication: 2015 Sep 04.
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-11 z 11

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies